Get answers to your Medical oncology for lung cancer questions.
Cancer - lung - non-small cell; Non-small cell lung cancer; NSCLC; Adenocarcinoma - lung; Squamous cell carcinoma - lung
There are three forms of NSCLC:
Smoking causes most cases of lung cancer. The risk depends upon the number of cigarettes smoked every day and for how long someone has smoked. Being around the smoke from others (secondhand smoke) also raises your risk for lung cancer. However, some people who do not smoke and have never smoked have developed lung cancer.
A review of decades of research has recently shown that smoking marijuana may help cancer cells grow, but there is no direct link between the drug and developing lung cancer.
High levels of air pollution and drinking water containing high levels of arsenic can increase your risk for lung cancer. Radiation therapy to the lungs can also increase the risk.
Working with or near the following cancer-causing chemicals or materials can also increase your risk:
Early lung cancer may not cause any symptoms. Symptoms you should watch for include:
Other symptoms that may be due to NSCLC:
Note: These symptoms can be due to other, less serious conditions. It is important to talk to your health care provider.
The health care provider will perform a physical exam and ask questions about your medical history. You will be asked if you smoke, and if so, how long you have smoked.
When listening to the chest with a stethoscope, the health care provider can sometimes hear fluid around the lungs, which could (but doesn't always) suggest cancer.
Tests that may be performed to diagnose lung cancer or see if it has spread include:
In some cases, the health care provider may need to remove a piece of tissue from your lungs for examination under a microscope. This is called a biopsy. There are several ways to do this:
If the biopsy reveals you do have lung cancer, more imaging tests will be done to determine the stage of the cancer. Stage means how big the tumor is and how far it has spread. Non-small cell lung cancer is divided into five stages:
There are many different types of treatment for non-small cell lung cancer. Treatment depends upon the stage of the cancer.
Surgery is the often the first line of treatment for patients with non-small cell lung cancer that has not spread beyond nearby lymph nodes. The surgeon may remove:
Some patients need chemotherapy. Chemotherapy uses drugs to kill cancer cells and stop new ones from growing.
Radiation therapy can be used with chemotherapy if surgery is not possible. Radiation therapy uses powerful x-rays or other forms of radiation to kill cancer cells. Radiation may be used to:
The following treatments are mostly used to relieve symptoms caused by NSCLC:
For additional information and resources, see cancer support group.
The outlook varies widely. Most often, NSCLC grows slowly and at first causes few or no symptoms. The cancer may spread to other parts of the body, including the bone, liver, small intestine, and brain.
However, in some cases, it can be extremely aggressive and cause rapid death. Chemotherapy has been shown to prolong the life and improve the quality of life in some patients with stage IV NSCLC.
Cure rates are related to the stage of disease and whether you are able to have surgery.
If you smoke, stop smoking. It's never too early to quit. Your risk of lung cancer drops dramatically the first year after you quit.
Try to avoid secondhand smoke.
See also: Lung Cancer
Alberg AJ, Ford JG, Samet JM; American College of Chest Physicians. Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:29S-55S.
American Cancer Society. Cancer Facts and Figures 2008. Atlanta, Ga: American Cancer Society; 2008.
Bach PB, Silvestri GA, Hanger M, Jett JR. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:69S-77S.
Jett JR, Schild SE, Keith RL, Kesler KA. Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132:266S-276S.
Johnson DH, Blot WJ, Carbone DP, et al. Cancer of the lung: non-small cell lung cancer and small cell lung cancer. In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKena WG. Clinical Oncology. 4th ed. Philadelphia, Pa: Churchill Livingstone Elsevier; 2008:chap 76.
Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A, Ravn J, Clementsen P, Høgholm A, Larsen K, Rasmussen T, Keiding S, Dirksen A, Gerke O, Skov B, Steffensen I, Hansen H, Vilmann P, Jacobsen G, Backer V, Maltbaek N, Pedersen J, Madsen H, Nielsen H, Højgaard L. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med. 2009;361:32-39.
Tassinari D, Scarpi E, Sartori S, Tamburini E, Santelmo C, Tombesi P, Lazzari-Agli L. Second-line treatments in non-small cell lung cancer. A systematic review of literature and metaanalysis of randomized clinical trials. Chest. 2009;135:1596-1609.
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885